Active Ingredient(s): Levosimendan
Category: Heart (Cardiac)

Simdax Overview

Levosimendan (INN) /livosamndn/ is a calcium sensitiser used in the management of acutely decompensated congestive heart failure. It is marketed under the trade name Simdax (Orion Corporation). Contents 1 Mechanism of action 2 Clinical use 2.1 Indications 2.2 Licensing status 2.3 Contraindications 2.4 Adverse effects 2.5 Formulations 3 References Mechanism of action Levosimendan is a calcium sensitizer — it increases the sensitivity of the heart to calcium, thus increasing car...

Read more Simdax Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Simdax Forums:

Be the first to start a discussion about this drug.

Other drugs which contain Levosimendan or a similar ingredient: (1 result)

Related Simdax Topics:

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA